StocksI › INNV

InnovAge Holding Corp. (INNV) — Earnings Call X-Ray

Our AI read all 30 of INNV's earnings calls (2016–2025) and answered the same battery of questions about each one. Every past call is free; the newest quarter unlocks with a free account.

Latest Call Grade
🔒
Q3 2025 · sign up to see
Previous Call Grade
C
Q2 2025
Expected Move
🔒
next 45 days · members
Calls Analyzed
30
2016–2025
Avg Candor
6.1/9
evasion 3/9
Skeptic ReassuredCritic AmmunitionUnderused Fixed CostsRaising PricesMargins ExpandingDemand AcceleratingQuestion Left HangingResults Worse Than Direction

Call-by-call analysis

🔒 Q3 2025 earnings call 2025-05-10 NEWEST

Guidance: ■■■■■Demand: ■■■■■■ Margins: ■■■■Backlog: ■■■■ ■ analysts, ■■ questionsexpected move ±■■%
Candor /9
Specificity /9
Evasion /9
Stress /9

Management ■■■■■■ guidance against ■■■■■■■■ demand and ■■■■■■■ margins. The delivery was ■■■■■■■■ and ■■■■ in specifics, with ■■■ questions left hanging.

🔒 The Q3 2025 call grade is ready
The full 37-point AI read of INNV's newest earnings call — grade, expected move, and every question answered — is free with an account.
Sign up free to unlock

C Q2 2025 earnings call 2025-02-04 move ±17.4%

Management held guidance steady against accelerating demand and expanding margins. The delivery was rich in specifics.

Guidance: maintainedDemand: acceleratingMargins: expandingPricing: raisingHeadcount: growingCapex: flat 4 analysts · 8 questions
⚑ Critic ammunition✓ Skeptic reassured⚑ Question left hanging✓ Guidance underwritable✓ Resolves doubtsDirection beats results
Candor 6/9
Specificity 7/9
Evasion 3/9
Confidence 7/9
Uncertainty 4/9
Promotion 5/9
Stress 3/9
Complexity 6/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
YES Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
YES Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

B Q1 2025 earnings call 2024-11-05 move ±11.7%

Management held guidance steady against steady demand and expanding margins. The delivery was unusually candid, rich in specifics.

Guidance: maintainedDemand: stableMargins: expandingBacklog: shrinkingPricing: raisingHeadcount: growingCapex: flat 3 analysts · 6 questions
⚑ Critic ammunition✓ Skeptic reassured⚑ Question left hanging✓ Guidance underwritable✓ Resolves doubts⚑ Reads rehearsed
Candor 7/9
Specificity 8/9
Evasion 2/9
Confidence 7/9
Uncertainty 4/9
Promotion 4/9
Stress 2/9
Complexity 5/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

C+ Q4 2024 earnings call 2024-09-10 move ±14.4%

Management held guidance steady against steady demand and expanding margins. The delivery was unusually candid, rich in specifics.

Guidance: maintainedDemand: stableMargins: expandingPricing: raisingHeadcount: growingCapex: flat 3 analysts · 6 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts⚑ Reads rehearsedCFO dominates
Candor 7/9
Specificity 8/9
Evasion 2/9
Confidence 7/9
Uncertainty 4/9
Promotion 5/9
Stress 3/9
Complexity 5/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
YES Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
YES Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
YES Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

C Q3 2024 earnings call 2024-05-12 move ±15.8%

Management held guidance steady against mixed demand signals. The delivery was unusually candid, rich in specifics.

Guidance: maintainedDemand: mixedMargins: stablePricing: under pressureHeadcount: growingCapex: flat 1 analysts · 3 questions
⚑ Critic ammunition⚑ Question left hanging✓ Resolves doubts⚑ Reads rehearsedDirection beats results
Candor 7/9
Specificity 8/9
Evasion 2/9
Confidence 6/9
Uncertainty 5/9
Promotion 4/9
Stress 3/9
Complexity 6/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

D Q2 2024 earnings call 2024-02-06 move ±13.1%

Management held guidance steady against accelerating demand and expanding margins. The delivery was unusually candid.

Guidance: maintainedDemand: acceleratingMargins: expandingBacklog: growingPricing: under pressureHeadcount: growingCapex: flat 3 analysts · 9 questions
⚑ Critic ammunition⚑ Question left hanging✓ Guidance underwritableDirection beats results
Candor 7/9
Specificity 6/9
Evasion 3/9
Confidence 7/9
Uncertainty 4/9
Promotion 5/9
Stress 3/9
Complexity 6/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

C Q1 2024 earnings call 2023-11-11 move ±14.1%

Management held guidance steady against accelerating demand and expanding margins. The delivery was rich in specifics.

Guidance: maintainedDemand: acceleratingMargins: expandingPricing: stableHeadcount: growingCapex: flat 2 analysts · 4 questions
⚑ Critic ammunition✓ Guidance underwritable✓ Resolves doubts✓ Volume step-up ahead⚑ Reads rehearsedDirection beats results
Candor 6/9
Specificity 7/9
Evasion 2/9
Confidence 7/9
Uncertainty 5/9
Promotion 5/9
Stress 3/9
Complexity 6/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?
From the research question bank
2 more research questions answered NO

C+ Q4 2023 earnings call 2023-09-12 move ±13.7%

Management gave no formal guidance against accelerating demand and contracting margins. The delivery was rich in specifics.

Demand: acceleratingMargins: contractingPricing: raisingHeadcount: growingCapex: flat 3 analysts · 7 questions
⚑ Critic ammunition✓ Skeptic reassured⚑ Question left hanging✓ Resolves doubts✓ Prepayments growing✓ Volume step-up ahead
Candor 6/9
Specificity 8/9
Evasion 3/9
Confidence 7/9
Uncertainty 5/9
Promotion 5/9
Stress 2/9
Complexity 4/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
YES Are deferred revenue or customer prepayments growing?
YES Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

Earlier calls

CallDateGradeGuidanceDemandMarginsCandorEvasion
Q3 2023 2023-05-13 D noneacceleratingexpanding 7/9 4/9
Q2 2023 2023-02-07 C nonemixedcontracting 7/9 3/9
Q1 2023 2022-11-11 C noneslowingcontracting 8/9 2/9
Q4 2022 2022-09-13 F withdrawnmixedcontracting 7/9 3/9
Q3 2022 2022-05-15 F withdrawnslowingcontracting 8/9 2/9
Q2 2022 2022-02-09 F withdrawnslowingcontracting 7/9 5/9
Q1 2022 2021-11-13 F maintainedacceleratingcontracting 6/9 4/9
Q4 2021 2021-09-21 F maintainedacceleratingcontracting 5/9 6/9
Q3 2021 2021-05-11 C+ maintainedacceleratingcontracting 6/9 3/9
Q2 2019 2019-08-13 D maintainedstableexpanding 6/9 3/9
Q1 2019 2019-05-15 F maintainedacceleratingcontracting 6/9 4/9
Q4 2018 2019-04-01 F maintainedacceleratingexpanding 5/9 4/9
Q3 2018 2018-11-14 F maintainedacceleratingstable 5/9 3/9
Q2 2018 2018-08-14 F raisedacceleratingstable 5/9 3/9
Q1 2018 2018-05-14 F maintainedacceleratingexpanding 5/9 4/9
Q4 2017 2018-04-02 D raisedacceleratingexpanding 6/9 3/9
Q3 2017 2017-11-14 F maintainedacceleratingstable 6/9 3/9
Q2 2017 2017-08-14 D maintainedacceleratingexpanding 6/9 2/9
Q2 2017 2017-05-12 D maintainedacceleratingexpanding 6/9 2/9
Q4 2016 2017-03-06 C+ raisedacceleratingexpanding 6/9 2/9
Q3 2016 2016-11-11 F maintainedacceleratingexpanding 4/9 2/9
Q2 2016 2016-08-09 D maintainedacceleratingexpanding 4/9 2/9

How to read this page

The grade is a transparent composite of call quality — candor, specificity, low evasion, low stress, whether the call resolves more doubts than it creates, and the guidance action — not a buy or sell signal. The expected move is a volatility estimate from the one signal that survived our out-of-sample tests: how a stock's own reaction and pre-call volatility predict the size (not direction) of its next move. Full detail, including everything that failed: methodology.

Companies with similar call quality

AAP · Advance Auto Parts, Inc.ABCAF · Athabasca Minerals, Inc.ABDC · Alcentra Capital'sABMD · Abiomed, Inc.ABNRY · ABN AMRO Bank N.V.ABOS · Acumen Pharmaceuticals,

INNT   All “I” companies    INO

Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.